FDA Inspection 1251735 — American Red Cross Blood Services
The FDA completed an inspection of American Red Cross Blood Services on Sep 30, 2024 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 30, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Omaha, NE (United States)